Australia markets open in 4 hours 22 minutes

Shanghai Xuerong Biotechnology Co.,Ltd. (300511.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
2.64000.0000 (0.00%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.32B
Enterprise value 3.47B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.57
Price/book (mrq)0.84
Enterprise value/revenue 1.49
Enterprise value/EBITDA -41.49

Trading information

Stock price history

Beta (5Y monthly) 0.13
52-week change 3-62.61%
S&P500 52-week change 326.24%
52-week high 37.9900
52-week low 32.5800
50-day moving average 33.5322
200-day moving average 34.8104

Share statistics

Avg vol (3-month) 319.18M
Avg vol (10-day) 325.08M
Shares outstanding 5498.78M
Implied shares outstanding 6498.78M
Float 8380.72M
% held by insiders 126.07%
% held by institutions 15.51%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.12
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 414 May 2021
Last split factor 21.9:1
Last split date 323 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -17.43%
Operating margin (ttm)5.49%

Management effectiveness

Return on assets (ttm)-4.50%
Return on equity (ttm)-24.99%

Income statement

Revenue (ttm)2.33B
Revenue per share (ttm)4.63
Quarterly revenue growth (yoy)-28.30%
Gross profit (ttm)N/A
EBITDA -18.84M
Net income avi to common (ttm)-405.53M
Diluted EPS (ttm)-0.8200
Quarterly earnings growth (yoy)-97.60%

Balance sheet

Total cash (mrq)647.88M
Total cash per share (mrq)1.3
Total debt (mrq)2.8B
Total debt/equity (mrq)193.16%
Current ratio (mrq)0.66
Book value per share (mrq)3.13

Cash flow statement

Operating cash flow (ttm)142.17M
Levered free cash flow (ttm)-929.89M